OpenVSafe by OpenVAERS
Search V-safe

M4T-17148-76487

3 vaccinations 2 coded responses 13 check-ins 2 free-text entries 2 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
959 / CA
Registered
2021-01-06
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-21
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-06
    Registered in v-safe
  3. 2021-01-06
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  4. 2021-01-11
    Dose 2 — Pfizer-BioNTech
  5. 2021-01-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Adverse reaction — Feeling: Fair · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: All started at 26 hours after vaccine
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-01-12
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  7. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  8. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Diarrhea
    Adult check-in
  9. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-01-18
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-01-27
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-02-08
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-07-12
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-09-02
    Dose 3 — Pfizer-BioNTech
  17. 2021-09-28
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-03-05
    Survey response — 6 months, dose 3
    MedDRA: Rash — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Forearm rash, unsure of cause
    MedDRA releases: 2024-11 · check-in free text available
  19. 2022-03-05
    Report sent to call center — 6 months, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  20. 2022-03-07

Vaccinations

DoseDateManufacturerCo-administered
12020-12-21Pfizer-BioNTech
22021-01-11Pfizer-BioNTech
32021-09-02Pfizer-BioNTech No

Call center

2 call center cases

1 unsuccessful · 1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-12

Systemic reaction (other): All started at 26 hours after vaccine

Release 11 — 6 months, dose 3

2022-03-05

Symptoms: Forearm rash, unsure of cause

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDRash · · ✓
SROAdverse reaction ✓ ✓ ✓
SROUnevaluable event ○ ○ ○

✓ active code · ○ coded but marked inactive · blank = not in that release